ArriVent BioPharma, Inc. Common Stock

AVBP

AVBPArriVent BioPharma, Inc. Common Stock US flag

NASDAQ Global Market

29.92

USD

-0.76

- -

1.39BMarket Cap

Income Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -
- Operating Expenses	- -	37	75	94	178
+ Selling, General & Admin	- -	6	10	15	24
+ Research & Development	- -	30	65	79	153
+ Other Operating Expense	- -	- -	- -	- -	- -
Operating Income (Loss)	- -	-37	-75	-94	-178
- Non-Operating (Income) Loss	- -	- -	-5	-14	-11
+ Interest Expense, Net	- -	- -	-5	-14	-11
+ Interest Expense	- -	- -	- -	- -	- -
- Interest Income	- -	- -	5	14	11
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	- -
Pretax Income	- -	-37	-69	-80	-166
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	- -	-37	-69	-80	-166
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	- -	-37	-69	-80	-166
- Minority Interest	- -	- -	- -	- -	- -
Net Income, GAAP	- -	-37	-69	-80	-166
- Preferred Dividends	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	- -	-37	-69	-80	-166
EBIT	- -	-37	-75	-94	-178
EBITDA	- -	-37	-75	-94	-178
EBITDA Margin (%)	- -	- -	- -	- -	- -
EBITA	- -	-37	-75	-94	-178
Gross Margin (%)	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	32	32	31	- -
Basic EPS, GAAP	- -	-1.15	-2.17	-2.56	- -
Basic EPS from Cont Ops	- -	-1.15	-2.17	-2.56	- -
Diluted Weighted Avg Shares	- -	32	32	31	- -
Diluted EPS, GAAP	- -	-1.15	-2.17	-2.56	- -
Diluted EPS from Cont Ops	- -	-1.15	-2.17	-2.56	- -

Balance Sheet (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	43	183	160	227	333
+ Cash, Cash Equivalents & STI	37	163	150	219	313
+ Cash & Cash Equivalents	37	163	150	74	46
+ ST Investments	- -	- -	- -	145	267
+ Accounts & Notes Receiv	- -	- -	1	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	1	- -	- -
+ Inventories	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -
+ Other ST Assets	5	19	9	8	20
+ Misc ST Assets	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	3	48	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	48	- -
+ LT Investments	- -	- -	- -	48	- -
+ LT Receivables	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	3	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	3	- -	- -
Total Assets	43	183	163	275	333
+ Payables & Accruals	1	6	8	13	19
+ Accounts Payable	- -	3	5	4	6
+ Accrued Taxes	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -
+ Other Payables & Accruals	1	2	4	9	13
+ ST Debt	- -	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -
+ Other ST Liabilities	1	3	3	4	7
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Misc ST Liabilities	1	3	3	4	7
Total Current Liabilities	2	8	12	17	26
+ LT Debt	- -	- -	- -	- -	- -
+ LT Borrowings	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	- -
+ Other LT Liabilities	- -	260	304	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	260	304	- -	- -
Total Noncurrent Liabilities	- -	260	305	- -	- -
Total Liabilities	2	268	316	17	26
+ Preferred Equity and Hybrid Capital	90	- -	- -	- -	- -
+ Share Capital & APIC	3	3	5	496	712
+ Common Stock	- -	- -	- -	- -	- -
+ Additional Paid in Capital	3	3	5	496	712
- Treasury Stock	- -	- -	- -	- -	- -
+ Retained Earnings	-52	-89	-158	-238	-405
+ Other Equity	- -	- -	- -	- -	- -
Equity Before Minority Interest	41	-85	-153	258	307
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
Total Equity	41	-85	-153	258	307
Total Liabilities & Equity	43	183	163	275	333
Shares Outstanding	32	32	32	34	42
Number of Employees	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -
Net Debt	-37	-163	-150	-74	-46
Net Debt to Equity	-90.44	191.96	98.17	-28.83	-14.82
Tangible Common Equity Ratio	-113.02	-46.55	-93.93	93.71	92.21
Current Ratio	23.63	21.84	13.76	13.14	12.83
Cash Conversion Cycle	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	- -	-37	-69	-80	-166
+ Depreciation & Amortization	- -	- -	- -	- -	- -
+ Non-Cash Items	- -	- -	1	3	9
+ Stock-Based Compensation	- -	- -	1	3	13
+ Deferred Income Taxes	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	- -	-3
+ Chg in Non-Cash Work Cap	- -	-7	13	7	-4
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-14	10	1	-13
+ Inc (Dec) in Accts Payable	- -	6	3	6	9
+ Inc (Dec) in Other	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Operating Activities	- -	-44	-56	-70	-161
+ Change in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	186	203
+ Increase in Capital Stock	- -	- -	- -	186	203
+ Decrease in Capital Stock	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	-192	-71
+ Dec in LT Investment	- -	- -	25	2	202
+ Inc in LT Investment	- -	- -	-25	-194	-273
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	-192	-71
+ Dividends Paid	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -
+ Other Financing Activities	- -	170	43	1	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Financing Activities	- -	170	43	187	203
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -
Net Changes in Cash	- -	126	-13	-76	-29
EBITDA	- -	-37	-75	-94	-178
EBITDA Margin (%)	- -	- -	- -	- -	- -
Free Cash Flow	- -	-44	-56	-70	-161
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-133	-56	-70	-161
Free Cash Flow per Basic Share	- -	-1.37	-1.75	-2.23	- -
Price/Free Cash Flow	- -	- -	- -	-11.94	- -
Cash Flow to Net Income	- -	1.18	0.81	0.87	0.97
Capital Expenditures	- -	- -	- -	- -	- -